Clinical Trial

ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)

Name: ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes) — clinical trial record (NCT07565467)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To help people with high-risk cancer variants to follow cancer surveillance guidelines and lower their risk of developing the disease.

Trial Details

NCT Number	NCT07565467
Lead Sponsor	M.D. Anderson Cancer Center
Conditions	ACT-GEN, Genetic Cancer Syndromes
Enrollment	80 participants
Start Date	2026-10-08
Primary Completion	2031-03-01 (estimated)
Study Completion	2033-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-04